What this topic covers
Part 3A of the 2022 content outline: controlled substance registration, ordering, records and inventories, losses, sourcing, returns, disposal, security and emergencies. These are original practice notes, not materials of the California State Board of Pharmacy or PSI, based on the texts in force on January 1, 2027. When California and federal law both apply, the stricter rule governs. Time limits, thresholds and quantities can change with each year's legislation. Nothing here is medical advice.
Registration and ordering
- DEA registration: renewed every 36 months for a pharmacy (21 CFR 1301.13(d); as of January 1, 2027; check for later changes).
- DEA Form 222: one supplier, one item per line, signed by the registrant or a power of attorney holder (21 CFR 1305.12); a defective form may not be corrected (21 CFR 1305.15(d)) and is kept on file (21 CFR 1305.17(a)).
- Power of attorney: signed by an officer, the grantee and two witnesses, kept with order records (21 CFR 1305.05(d)).
- CSOS: a digital signature issued by DEA under part 1311 (21 CFR 1305.21(a)).
Records and inventories
- Receipt: record the date actually received (21 CFR 1304.21(d)); dispensing records show name, address, date, units and dispenser (21 CFR 1304.22(c)).
- Biennial inventory: within two years of the previous one (21 CFR 1304.11(c)); exact count for an opened Schedule I or II container (21 CFR 1304.11(e)(6)(i)).
- Filing: Schedule I and II records kept separately (21 CFR 1304.04(h)(1)).
- California reconciliation: every 12 months for listed drugs such as alprazolam 1 milligram/unit and 2 milligrams/unit and tramadol 50 milligrams/unit (16 CCR 1715.65(a)(2); as of January 1, 2027; check for later changes); the counter and the pharmacist-in-charge both sign (section 1715.65(c)(1), (e)(1)).
Loss and theft
- Federal: written notice to DEA within one business day of discovery, DEA Form 106 within 45 days (21 CFR 1301.76(b); as of January 1, 2027; check for later changes).
- California: employee theft is reported to the Board regardless of amount (16 CCR 1715.6(a)(2)); theft losses within 14 days (16 CCR 1715.65(d)); evidence of theft by a licensee within 14 days (B&P Code section 4104(c)(4); as of January 1, 2027; check for later changes). DEA Form 41 records destruction, not theft.
Sourcing, returns and disposal
- Sources: buy only from a licensed wholesaler, third-party logistics provider or pharmacy (B&P Code section 4169(a)(1); section 4163(b)).
- Expiration: drugs without a manufacturer's expiration date are deemed expired (16 CCR section 1718.1).
- Reverse distributor: may receive outdated drugs (B&P Code section 4126.5(a)(3)); destroys controlled substances within 30 calendar days (21 CFR 1317.15(d); as of January 1, 2027; check for later changes).
- Take-back: consumers may deposit Schedule II-V drugs; pharmacy stock may not go in a receptacle (16 CCR section 1776.1).
Security and emergencies
- Keys: an owner's key in a tamper evident container signed by the pharmacist-in-charge (16 CCR section 1714(e)).
- Deliveries: to a closed pharmacy only into secure storage (B&P Code section 4059.5(f)); via a hospital within one working day (section 4059.5(c); as of January 1, 2027; check for later changes).
- Emergency: a mobile pharmacy stops within 48 hours of the end of the emergency (B&P Code section 4062(c)(6); as of January 1, 2027; check for later changes).
- Pseudoephedrine: photo identification issued by a State or the Federal Government, or another accepted document, and a logbook signature (21 CFR 1314.30(b)).
Sample questions (5)
1. After its initial registration period, a retail pharmacy's DEA registration runs for:
- 1 year
- 2 years
- 3 years
- 5 years
21 CFR 1301.13(d) provides that after the initial period “the registration expires 36 months from the initial expiration date”, so the cycle for a retail pharmacy is three years. The one-year period in the 1301.13(e) table applies to manufacturers, distributors and researchers, not to dispensers, and the table lists no two-year or five-year registration period.
2. The owner of Maple Grove Pharmacy, which holds a DEA registration for its current address, opens a second pharmacy in another city.
The owner plans to dispense Schedule II drugs at the new site.
What must the owner do regarding DEA registration?
- Use the current registration, since the owner is the same
- Add the new site to the current registration by notifying the Board
- Keep the stock at the current site and deliver it to the new site
- Obtain a separate DEA registration for the new location
21 CFR 1301.12(a) requires a separate registration for “each principal place of business or professional practice at one general physical location” where controlled substances are dispensed. Common ownership does not let one registration cover two locations, and none of the exceptions in section 1301.12(b) fits a second dispensing pharmacy. Moving stock to the new site would still mean dispensing at an unregistered location, and a Certificate of Registration is issued by the DEA Administrator under section 1301.13(a), so a notice to the Board cannot extend it to a second site.
3. Cedar Ridge Pharmacy is selling its business to Harbor View Pharmacy, and both hold DEA registrations.
The transfer of the controlled substances is set for June 12, and the required advance notice has been sent.
What must be done on June 12?
- Take one complete inventory that serves as the final and initial inventory
- Have each pharmacy estimate the stock and reconcile it within 30 days
- Return the stock to a reverse distributor and place new orders
- File DEA Form 106 listing every controlled substance transferred
Under 21 CFR 1301.52(e)(1), “a complete inventory of all controlled substances being transferred shall be taken” on the date of transfer, and that inventory is the transferor's final inventory and the transferee's initial inventory. Schedule I and II stock must also move on order forms under part 1305. DEA Form 106 reports a theft or loss, and nothing in section 1301.52 requires a return to a reverse distributor.
4. Under 21 CFR 1304.11, controlled substances are deemed “on hand” for inventory purposes when they are:
- stored in the pharmacy's locked controlled substance cabinet
- listed in the pharmacy's dispensing software on the inventory date
- paid for by the registrant and shown on a posted invoice
- in the possession of or under the control of the registrant
Section 1304.11(a) deems substances to be on hand “if they are in the possession of or under the control of the registrant”, which includes substances returned by a customer or ordered by a customer but not yet invoiced. Location in a cabinet, payment status and software records do not define what is on hand. Stock held at a location where the registrant is not registered is added to the inventory of the registered location it is controlled from.
5. The last biennial inventory of controlled substances at Willow Creek Pharmacy was taken on May 4, 2025.
The pharmacist-in-charge is scheduling the next biennial inventory.
Under federal law, what is the latest date on which it may be taken?
- May 4, 2026
- November 4, 2026
- May 4, 2027
- May 4, 2028
21 CFR 1304.11(c) requires a new inventory at least every two years and allows it on any date “within two years of the previous biennial inventory date”, so the latest date is May 4, 2027. The two earlier dates are allowed but are not the latest, and May 4, 2028 is three years after the last inventory, beyond the two-year limit. California adds its own reconciliation schedule in 16 CCR section 1715.65, which this question does not test.